1-Discuss clinical features and laboratory markers can be used to classify pediatric patients with febrile neutropenia (FN ) as being at low or high risk for poor outcomes?

2-Discuss the research question;  Does depth and duration of neutropenia at presentation predict outcomes? Comparison between IDSA guidelines and my research study results

3-Discuss the research question; Prolonged vs recurrent FN; Should management differ ?



Session date: 
06/19/2017 - 12:00pm to 1:00pm CDT
UCMC C-400
Chicago, IL 60637
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Muayad Alali, MD